UNSPSC 51285302: Furazolidone

This classification denotes an anti-infective agent with the molecular formula C8H7N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 5J9CPU3RE0, chemically known as 2-furanmethanimine, 5-nitro-n-(2-oxo-3-oxazolidinyl)- but more generally known as furazolidone, which bears US NIH Compound Identifier 3435. European Medicines Agency schedules Furazolidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07834MIG.

UNSPSC 51285302 Furazolidone is a Commodity code that nominally designates a specific pharmaceutical active ingredient, but recent state and local solicitations tagged under this code actually encompass a much broader range of medical supplies, pharmaceuticals, and health-related products including naloxone, drug deactivation systems, first-aid supplies, generic multi-source pharmaceuticals, and over-the-counter products. State and local governments procuring under this code include county health departments, city fire and rescue divisions, state health and human services agencies, and cooperative purchasing alliances spanning multiple states. The scope of work ranges from emergency medical supplies for fire department rescue operations to community health initiatives, pharmacy benefit program management, and bulk pharmaceutical distribution through authorized wholesaler networks. Issuing bodies include Seminole County, Florida; the City of Tampa; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), which administers purchasing for multiple member states including Oregon.

Recent activity spans Florida, Texas, Minnesota, and Oregon. Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB60459723LAS, due July 26, 2023); the City of Tampa's sealed-bid solicitation for 169 line items of medical and first-aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000 and a SLBE set-aside with a 5 percent bid discount (26P00145, due March 13, 2026); the Texas HHS Commission's Request for Information on direct-to-manufacturer prescription programs (HHS0017013, posted April 3, 2026); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products across participating state and local facilities (S1070000015802, due March 26, 2026). The code shows activity across health departments, emergency services, and statewide cooperative purchasing vehicles, though the mismatch between the code's nominal scope (a single pharmaceutical ingredient) and the actual procurement breadth suggests inconsistent UNSPSC tagging in source systems.